Details
Title
Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia
Author
Dun, Matthew D 1
; Mannan, Abdul 1 ; Rigby, Callum J 1 ; Butler, Stephen 2 ; Toop, Hamish D 2
; Beck, Dominik 3 ; Connerty, Patrick 4 ; Sillar, Jonathan 5 ; Kahl, Richard G, S 1 ; Duchatel, Ryan J 1 ; Germon Zacary 1 ; Faulkner, Sam 1
; Mengna, Chi 1 ; Skerrett-Byrne, David 6 ; Murray, Heather C 1 ; Flanagan, Hayley 1 ; Almazi, Juhura G 7 ; Hondermarck Hubert 1 ; Nixon, Brett 6 ; De Iuliis Geoff 6
; Chamberlain, Janis 8 ; Frank, Alvaro 8 ; de Bock Charles E 4
; Morris, Jonathan C 2
; Enjeti, Anoop K 9 ; Verrills, Nicole M 1
1 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c)
2 University of New South Wales, School of Chemistry, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
3 University of Technology Sydney, Centre for Health Technologies and the School of Biomedical Engineering, Sydney, Australia (GRID:grid.117476.2) (ISNI:0000 0004 1936 7611); University of New South Wales, Lowy Cancer Research Centre and the Prince of Wales Clinical School, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
4 University of New South Wales, Children’s Cancer Institute Australia, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
5 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c); Calvary Mater Hospital, Newcastle, Australia (GRID:grid.416562.2) (ISNI:0000 0004 0642 1666)
6 Reproductive Science Group, Faculty of Science, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X)
7 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c); University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, Australia (GRID:grid.117476.2) (ISNI:0000 0004 1936 7611)
8 Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c); John Hunter Children’s Hospital, New Lambton Heights, Australia (GRID:grid.422050.1) (ISNI:0000 0004 0640 1972)
9 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c); Calvary Mater Hospital, Newcastle, Australia (GRID:grid.416562.2) (ISNI:0000 0004 0642 1666); John Hunter Hospital, NSW Health Pathology, New Lambton Heights, Australia (GRID:grid.414724.0) (ISNI:0000 0004 0577 6676); University of Newcastle, School of Medicine and Public Health, Faculty of Health and Medicine, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X)
; Mannan, Abdul 1 ; Rigby, Callum J 1 ; Butler, Stephen 2 ; Toop, Hamish D 2
; Beck, Dominik 3 ; Connerty, Patrick 4 ; Sillar, Jonathan 5 ; Kahl, Richard G, S 1 ; Duchatel, Ryan J 1 ; Germon Zacary 1 ; Faulkner, Sam 1
; Mengna, Chi 1 ; Skerrett-Byrne, David 6 ; Murray, Heather C 1 ; Flanagan, Hayley 1 ; Almazi, Juhura G 7 ; Hondermarck Hubert 1 ; Nixon, Brett 6 ; De Iuliis Geoff 6
; Chamberlain, Janis 8 ; Frank, Alvaro 8 ; de Bock Charles E 4
; Morris, Jonathan C 2
; Enjeti, Anoop K 9 ; Verrills, Nicole M 1 1 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c)
2 University of New South Wales, School of Chemistry, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
3 University of Technology Sydney, Centre for Health Technologies and the School of Biomedical Engineering, Sydney, Australia (GRID:grid.117476.2) (ISNI:0000 0004 1936 7611); University of New South Wales, Lowy Cancer Research Centre and the Prince of Wales Clinical School, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
4 University of New South Wales, Children’s Cancer Institute Australia, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
5 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c); Calvary Mater Hospital, Newcastle, Australia (GRID:grid.416562.2) (ISNI:0000 0004 0642 1666)
6 Reproductive Science Group, Faculty of Science, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X)
7 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c); University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, Australia (GRID:grid.117476.2) (ISNI:0000 0004 1936 7611)
8 Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c); John Hunter Children’s Hospital, New Lambton Heights, Australia (GRID:grid.422050.1) (ISNI:0000 0004 0640 1972)
9 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X); Cancer Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia (GRID:grid.413648.c); Calvary Mater Hospital, Newcastle, Australia (GRID:grid.416562.2) (ISNI:0000 0004 0642 1666); John Hunter Hospital, NSW Health Pathology, New Lambton Heights, Australia (GRID:grid.414724.0) (ISNI:0000 0004 0577 6676); University of Newcastle, School of Medicine and Public Health, Faculty of Health and Medicine, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X)
Pages
3393-3397
Publication year
2020
Publication date
Dec 2020
ISSN
08876924
e-ISSN
14765551
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2473252043
Copyright
© The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.